Return
Company Page
Anodyne Nanotech
Anodyne Nanotech is a venture-backed, preclinical-stage biotechnology company redefining drug delivery through its proprietary macroporous microneedle technology. Its flagship Hero Patch platform delivers clinically meaningful, multi-milligram doses of macromolecules such as monoclonal antibodies and GLP-1 receptor agonists transdermally, eliminating the need for injections. Founded in 2019 and headquartered in Boston, MA, the company is targeting high-value therapeutics including obesity and rheumatoid arthritis treatments.
Company Founded in 2019
Healthtech & Biotech